XML 34 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (shares) at Dec. 31, 2022   26,727,458      
Beginning balance at Dec. 31, 2022 $ 192,900 $ 5 $ 301,732 $ (74) $ (108,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (23,419)       (23,419)
Recognition of stock-based compensation expense 3,906   3,906    
Exercise of vested stock options (shares)   6,443      
Exercise of vested stock options 13   13    
Issuance of common stock upon the vesting of restricted stock units (shares)   66,611      
Other comprehensive loss 4     4  
Ending balance (shares) at Mar. 31, 2023   26,800,512      
Ending balance at Mar. 31, 2023 $ 173,404 $ 5 305,651 (70) (132,182)
Beginning balance (shares) at Dec. 31, 2023 34,211,190 34,211,190      
Beginning balance at Dec. 31, 2023 $ 196,988 $ 5 441,641 (2) (244,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (35,731)       (35,731)
Recognition of stock-based compensation expense 5,519   5,519    
Issuance of common stock, net of issuance costs (shares)   3,281,250      
Issuance of common stock, net of issuance costs of $6.7 million 98,329 $ 1 98,328    
Issuance of pre-funded warrants, net of issuance costs of $0.6 million $ 9,365   9,365    
Exercise of vested stock options (shares) 49,310 49,310      
Exercise of vested stock options $ 802   802    
Issuance of common stock upon the vesting of restricted stock units (shares)   207,718      
Other comprehensive loss $ (61)     (61)  
Ending balance (shares) at Mar. 31, 2024 37,749,468 37,749,468      
Ending balance at Mar. 31, 2024 $ 275,211 $ 6 $ 555,655 $ (63) $ (280,387)